reference/12253773

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12253773

Outgoing Links

Predicate	Object
contentType	Evaluation Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Review\|Systematic Review
endingPage	xiii, 1
issn	1366-5278 2046-4924
issueIdentifier	23
pageRange	iii-xiii, 1
publicationName	Health technology assessment (Winchester, England)
startingPage	iii
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5d10530eeb9c2e5699014abbfff60e1
bibliographicCitation	Loveman E, Cooper K, Bryant J, Colquitt JL, Frampton GK, Clegg A. Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technol Assess. 2012;16(23):iii–xiii, 1. PMID: 22564553; PMCID: PMC4781455.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4724bdb26f38ec232b1c807cc4422ee5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5962-2689 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f58ff3ac0cc60d05c3bfd6be243da28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8af02ac7b0695ca5da0a044eedfc78d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9eed08883fdccd4092834782f4663630 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a91b270cb67e0afd1655464bb064e8e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2801e0ef7283741cfd135923f87c90b
date	201205
identifier	https://pubmed.ncbi.nlm.nih.gov/22564553 https://pubmed.ncbi.nlm.nih.gov/PMC4781455 https://doi.org/10.3310/hta16230
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20788 https://portal.issn.org/resource/ISSN/1366-5278 https://portal.issn.org/resource/ISSN/2046-4924
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0391958
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003362 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D013844Q000191 http://id.nlm.nih.gov/mesh/D015464Q000191 http://id.nlm.nih.gov/mesh/D047428Q000191 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011743Q000191 http://id.nlm.nih.gov/mesh/D010879Q000191 http://id.nlm.nih.gov/mesh/D016001 http://id.nlm.nih.gov/mesh/D000970Q000191 http://id.nlm.nih.gov/mesh/D018803 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D006113 http://id.nlm.nih.gov/mesh/D004351 http://id.nlm.nih.gov/mesh/D019057 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D001549
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3657 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520807 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103

Total number of triples: 73.